Skip to content

Brief Admission for Adolescents Who Self-harm

Brief Admission by Self-referral for Adolescents Who Self-harm, at Risk for Suicide. A Qualitative Study to Optimise and Standardise the Intervention

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04962373
Enrollment
59
Registered
2021-07-15
Start date
2020-09-01
Completion date
2025-06-30
Last updated
2025-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Suicidal Self Injury, Self-Harm, Deliberate, Suicidal, Suicide, Attempted

Brief summary

There is still no consensus on how to manage suicidal behavior in youth with recurrent self-harm at times when the risk for suicide is imminent (1). Brief Admission (BA) has evolved as a promising crisis intervention for adults with self-harm (2). The characteristics of BA is different from other types of admission, being focused on prevention through increased autonomy and self-care, based on structured and voluntary brief self-referrals to hospital (3). As a result of a randomized controlled trial, BA is since January 2019, continuously offered to adults with self-harm at risk for suicide in Skåne (4). Parallel to this clinical trial, the method has been adapted to work in a psychiatric setting for adolescents. At present 24 adolescents have access to the method in Skåne. Clinical experiences from staff are promising, however, the lived experiences have not been collected in a standardized way. The aim of the present study is to gather information on how BA in its present, standardized form works for adolescents, their loved ones and staff working at the ward providing BA. This will be done through semi-structured interviews with: 1. Adolescents using BA and their loved ones 2. Staff working at the ward providing BA. Data will be analyzed with qualitative analysis (5, 6). The ultimate aim is to use these results to optimize the current standardized version of BA for adolescents in order to test in a randomized clinical trial.

Interventions

OTHERSemi-structured interviews

Each participant will attend a 30-60 minute semi-structured interview conducted by the CI

Sponsors

Lund University
CollaboratorOTHER
Region Skane
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
13 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

Sample 1: Inclusion Criteria: * Adolescents with an active BA contract * At least 13 years of age. * Able to consent to study participation through written and oral information. * Consent from caregivers * Given consent to participate

Exclusion criteria

* Below the age of 13. Sample 2: Inclusion Criteria: * Parents to adolescents with an active BA contract * At least 18 years of age. * Able to consent to study participation through written and oral information. * Given consent to participate

Design outcomes

Primary

MeasureTime frameDescription
Perceived effective components of Brief Admission for adolescents60minsQualitative data from interviews
Potential adaptations of the method to better fit adolescents60minsQualitative data from interviews
Areas where Brief Admission have the most prominent perceived effects in adolescents60minsQualitative data from interviews

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026